Group Discussion Deepens Over WHO Role In Stopping Poor Quality Medicines 01/03/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment The role of the World Health Organization in the safety, quality and efficacy of medical products is under scrutiny this week by member states and stakeholders. In particular, the focus is on the WHO’s role in the prevention and control of medical products of compromised quality, the organisation’s relationship with the international taskforce against counterfeit products, and the taskforce’s alleged focus on the protection of intellectual property rights rather than on public health issues. In several documents, the WHO tries to explain this fragile role.
Debate Rises Over Elevating Profile Of Genetic Resources At WIPO 01/03/2011 by Catherine Saez, Intellectual Property Watch 1 Comment Experts discussing the protection of genetic resources at the World Intellectual Property Organization this week are struggling to stay within their technical mandate as the issues carry significant political impact. Discussions today resulted in a marked-up text on objectives and principles of a possible international instrument that reveals key differences among members on the role of IP, and of WIPO, in genetic resources.
Are The Stars Aligned For US Patent Reform This Year? 01/03/2011 by William New, Intellectual Property Watch Leave a Comment In a week in which the United States Congress is fighting to avoid a government shutdown over budget disagreements and political posturing is high, technocrats and friends of innovative businesses are working to get passage of a bill to reform US patent law.
WHO Members To Work To Disentangle Problem Of Fake Medicines, IP Issues 26/02/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment A designated working group will meet for the first time this week to discuss the World Health Organization’s role in the safety, quality and efficacy of medical products, but some countries are concerned about what they consider to be the unwelcome intrusion of intellectual property rights issues into the debate.
After Folklore, Traditional Knowledge Makes Steps Toward WIPO Treaty Text 25/02/2011 by Catherine Saez, Intellectual Property Watch 4 Comments After a week of technical discussions to elaborate a draft text designed to help the World Intellectual Property Organization member states reach a treaty text on the protection of traditional knowledge, experts provided a set of draft articles, comments and proposed amendments.
Building A Consensus To Address The Health Threat Posed By Fake Medicines 25/02/2011 by Intellectual Property Watch 1 Comment On the eve of a meeting of the WHO working group on substandard/spurious/falsely-labelled/falsified/counterfeit medical products, research-based pharmaceutical industry group IFPMA sets out thoughts on building global consensus to address fake medicines.
WIPO Traditional Knowledge Experts In Small Groups To Craft Treaty Text 23/02/2011 by Catherine Saez, Intellectual Property Watch 3 Comments After two days of broad analysis of a draft document on traditional knowledge, country experts were to convene today in small drafting groups to trim down the language and arrive at a treaty negotiating text for the delegates meeting at the World Intellectual Property Organization in May.
Stronger IP Rights In EU-Korea FTA: Precedent For Future FTAs? 20/02/2011 by Monika Ermert for Intellectual Property Watch 9 Comments A European Parliament majority this week approved a free trade agreement with Korea with strong provisions on intellectual property rights protection, according to Robert Stury, rapporteur of the lead EP Committee on the dossier.
Brazil And The Defence Of Public Health: Do As I Say, Not As I Do 17/02/2011 by Intellectual Property Watch 3 Comments A recent decision issued by Advocacia-Geral da União (Advocacy-General of the Union) restricts the role performed by Anvisa – the National Agency for Health Surveillance – in examining pharmaceutical patent applications. This may represent a huge setback for commitments made by Brazilian government related to the protection of public health, writes Felipe Carvalho.
Economist: Breadth Of Patent Portfolio Better Than Betting On One Winner 11/02/2011 by Catherine Saez, Intellectual Property Watch 1 Comment Determining the value of patented inventions is akin to a guessing game, said a speaker at the World Intellectual Property Organization yesterday. Companies should try to spread their patents over related technological innovations rather focusing on one patent, hoping it will be “the philosopher’s stone”.